Argenx Says VYVGART Showed Continued Improvement In Ocular Myasthenia Gravis, Sustained One-Year Efficacy In Antibody-Negative Generalized MG

뉴스 본문을 불러오고 있어요.

Argenx Says VYVGART Showed Continued Improvement In Ocular Myasthenia Gravis, Sustained One-Year Efficacy In Antibody-Negative Generalized MG | 웨이프 WAPE

Argenx Says VYVGART Showed Continued Improvement In Ocular Myasthenia Gravis, Sustained One-Year Efficacy In Antibody-Negative Generalized MG

기사 요약

관련 종목

댓글 —